Healthcare -
Biotechnology - NASDAQ - US
$ 9.75
0.619 %
$ 752 M
Market Cap
-3.18
P/E
REPL - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities REPL - Replimune Group, Inc.
97.2 M
LAST VALUE
647.14%
2 YEAR CAGR
28.28%
5 YEAR CAGR
0.00%
10 YEAR CAGR